Related Experiment Video
Updated: Jul 4, 2026
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
Management of extremity soft tissue sarcomas
Matthew T Hueman1, Katherine Thornton, Joseph M Herman
1Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
The Surgical Clinics of North America
|June 3, 2008
Summary
This article details the evaluation, staging, and management of extremity soft tissue sarcomas. A multidisciplinary team approach is crucial for optimizing tumor control, functional outcomes, and minimizing therapy toxicity in these unique patient cases.
Area of Science:
- Oncology
- Surgical Oncology
- Musculoskeletal Oncology
Background:
- Extremity soft tissue sarcomas require careful evaluation and staging.
- Standard management guidelines exist, but individual patient factors are critical.
Purpose of the Study:
- To provide an understanding of the evaluation, staging, and management of extremity soft tissue sarcoma.
- To highlight the importance of individualized treatment considerations.
Main Methods:
- Review of current literature and clinical guidelines for soft tissue sarcoma management.
- Emphasis on a multidisciplinary team approach.
Main Results:
- Individualized assessment is necessary, balancing tumor control, functional outcomes, and treatment toxicity.
- A coordinated team approach ensures comprehensive patient care.
Conclusions:
- Effective management of extremity soft tissue sarcoma necessitates a tailored strategy.
- Multidisciplinary collaboration is key to optimizing patient care and outcomes.
